Newsroom

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) common stock between November 5, 2025 and February 4, 2026, inclusive (the “Class Period”). Coty investors have until May 22, 2026 to file a lead plaintiff motion.IF YOU SUFFERED A LOSS ON YOUR COTY INC. (...

BELGRAD, Serbien--(BUSINESS WIRE)--Die Telekom Srbija-Gruppe hat ihr internationales Einzelhandelsnetz mit der Eröffnung einer neuen MTEL Germany-Filiale in Offenbach, einem der wichtigsten Wachstumsmärkte des Unternehmens in Europa, weiter ausgebaut und damit ihr langfristiges Engagement für den Ausbau ihrer Präsenz in Deutschland bekräftigt. Die neue Filiale bietet ein umfassendes Portfolio an Produkten und Dienstleistungen von TSG unter der Marke MTEL Germany und schafft damit einen modernen...

DALLAS--(BUSINESS WIRE)--Sieve Capital LLC (collectively with its affiliates, “Sieve” or “we”), a shareholder of Americold Realty Trust, Inc. (“Americold” or the “Company”), today announced that it is reluctantly initiating a public campaign focused on Chairman Mark Patterson and his boardroom allies. Last week, in a private letter that the Board of Directors (the “Board”)1 has not acknowledged, Sieve detailed its serious concerns pertaining to Mr. Patterson’s documented history of apparently p...

MINNEAPOLIS--(BUSINESS WIRE)--Provation, a leading provider of clinical productivity software, announces the launch of Provation® Mira Documentation Assist, a voice-driven documentation capability within its cloud-based GI procedure platform, Provation® Apex, enabling real-time structured documentation during procedures. This hands-free technology allows clinicians to document in real-time by simply speaking, reducing the need for manual data entry and post-procedure recall. “Mira brings docume...

WASHINGTON & CHICAGO--(BUSINESS WIRE)--Nodal Exchange, in collaboration with IncubEx, launched the first financially settled California Carbon Allowance futures and options contracts....

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026, inclusive (the “Class Period”). Atara investors have until May 22, 2026 to file a lead plaintiff motion.IF YOU SUFFERED A LOSS ON Y...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 27.03.2026 FPX. IE00BYTH6238  175,002.00 USD  10,161,803.05   58.067  ...

MARKHAM, Ontario--(BUSINESS WIRE)--Il arrive un moment où un VUS compact ou intermédiaire devient insuffisant. Probablement parce que la famille s'agrandit. Les longs trajets sont peut-être plus fréquents. Ou peut-être souhaitez-vous simplement davantage de confort sans pour autant passer à un véhicule surdimensionné et énergivore. C’est généralement le moment où les acheteurs commencent à s’intéresser aux VUS pleine grandeur. Le problème, c’est qu’au Canada, opter pour un plus gros véhicule se...

PEKING & TOKIO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Peking) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), ein weltweit tätiges Biotechnologieunternehmen, das die Forschung und Entwicklung neuartiger, auf Antikörpern basierender Medikamente mit innovativen Technologien vorantreibt, hat heute den Abschluss einer Plattform-Lizenzvereinbarung mit Taisho Pharmaceutical Co., Ltd. („Taisho“) bekannt gegeben. Im Rahmen der Lizenzvereinbarung wird Taisho das Recht gewährt, auf die firmeneig...

BEIJING e TOKYO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), un'azienda biotecnologica globale a capo di ricerca e sviluppo di nuovi farmaci a base di anticorpi tramite tecnologie innovative, ha annunciato oggi di aver sottoscritto un accordo di licenza della piattaforma con Taisho Pharmaceutical Co., Ltd. ("Taisho"), che concederà a Taisho il diritto di accedere e utilizzare la piattaforma proprietaria di Biocytogen, RenNano® per il r...